We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Single-Cell RNA-Seq Reveals Cell Type–Specific Molecular and Genetic Associations to Lupus

By LabMedica International staff writers
Posted on 12 Apr 2022
Print article
Image: Lupus Erythematosus (LE) Cells are neutrophils that have engulfed lymphocyte nuclei coated with and denatured by antibody to nucleoprotein and are found in systemic lupus erythematosus (Photo courtesy of Dr. Moustafa Abdou, MB, BCh)
Image: Lupus Erythematosus (LE) Cells are neutrophils that have engulfed lymphocyte nuclei coated with and denatured by antibody to nucleoprotein and are found in systemic lupus erythematosus (Photo courtesy of Dr. Moustafa Abdou, MB, BCh)

Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease with elevated prevalence in women and individuals of Asian, African, and Hispanic ancestry. SLE is a disease in which the immune system attacks its own tissues, causing widespread inflammation and tissue damage in the affected organs. It can affect the joints, skin, brain, lungs, kidneys, and blood vessels.

Historically, flow cytometry and bulk transcriptomic analyses were used to profile the composition and gene expression of circulating immune cells in SLE. However, flow cytometry is biased by its use of a limited set of known markers, whereas bulk transcriptomic profiling does not have sufficient power to detect cell type–specific expression differences.

Medical Scientists at the University of California, San Francisco (San Francisco, CA, USA) and their colleagues used a method called "multiplexed scRNA-seq" (mux-seq), and they assessed more than 1.2 million peripheral blood mononuclear cells (PBMC) isolated from 162 individuals with SLE and 99 unaffected controls, drawn from the California Lupus Epidemiology Study and the Immune Variation project.

The scientists reported that analysis of lymphocyte composition revealed a reduction in naïve CD4+ T cells and an increase in repertoire-restricted GZMH+ CD8+ T cells. Analysis of transcriptomic profiles across eight cell types revealed that classical monocytes expressed the highest levels of both pan–cell type and myeloid-specific type 1 interferon–stimulated genes (ISGs). The expression of ISGs in monocytes was inversely correlated with naïve CD4+ T cell abundance. Cell type–specific expression features accurately predicted case-control status and stratified patients into molecular subtypes.

The investigators integrated genotyping data and using a novel matrix decomposition method, and mapped shared and cell type–specific cis–expression quantitative trait loci (cis-eQTLs) across eight cell types. Cell type–specific cis-eQTLs were enriched for regions of open chromatin specific to the same or related cell types. Joint analysis of cis-eQTLs and genome-wide association study results enabled identification of cell types relevant to immune-mediated diseases, fine-mapping of disease-associated loci, and discovery of novel SLE associations. Interaction analysis identified variants whose effects on gene expression are further modified by interferon activation across patients.

The authors concluded that SLE remains challenging to diagnose and treat. The heterogeneity of disease manifestations and treatment response highlight the need for improved molecular characterization. In a large multiethnic cohort, they demonstrated mux-seq as a systematic approach to characterize cellular composition, identify cell type–specific transcriptomic signatures, and annotate genetic variants associated with SLE. The study was published on April 8, 2022 in the journal Science.

Related Links:
University of California, San Francisco 


New
Gold Member
C-Reactive Protein Reagent
CRP Ultra Wide Range Reagent Kit
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
DNA topoisomerase I ELISA
Anti-Scl-70 ELISA Test
New
Lab Autoclave
T-Lab Eco

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The new assays will run on the QIAcuity digital PCR (dPCR) platform (Photo courtesy of QIAGEN)

New Digital PCR Assays Enable Accurate and Sensitive Detection of Critical Pathogens

QIAGEN (Venlo, the Netherlands) has introduced 100 new assays for its QIAcuity digital PCR (dPCR) platform, aimed at advancing research in areas such as cancer, inherited genetic disorders, and infectious... Read more

Pathology

view channel
Image: The new AI technology more precisely predicts the risk of getting breast cancer (Photo courtesy of William Brøns Petersen)

AI Technology Accurately Predicts Breast Cancer Risk Via ‘Zombie Cells’

Breast cancer remains one of the most common cancers worldwide, causing 670,000 deaths in 2022. A key aspect of assessing cancer risk involves identifying dying cells. A new study has demonstrated that... Read more

Industry

view channel
Image: International expert meeting for trends and innovations in laboratory medicine - the MEDICA LABMED FORUM at MEDICA (Photo courtesy of Constanze Tillmann/Messe Düsseldorf)

MEDICA LABMED FORUM 2024: International Experts Meet to Discuss Trending Topics in Laboratory Medicine

At MEDICA (Düsseldorf, Germany), the world’s premier trade fair for the healthcare industry and medical technology sector, this year’s event (November 11–14) will focus on the most exciting medical advancements.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.